![Craig B. Bleifer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Craig B. Bleifer
Corporate Officer/Principal chez
Pharmaceutical Research & Manufacturers of America
Profil
Craig B. Bleifer is currently a Member at the Pharmaceutical Research & Manufacturers of America.
Previously, he served as Vice Chairman at the HealthCare Institute of New Jersey.
From 2000 to 2018, he held the positions of Secretary, Senior Vice President & General Counsel at Daiichi Sankyo, Inc. Mr. Bleifer completed his undergraduate degree at Vassar College and his graduate degree at New York University School of Law.
Postes actifs de Craig B. Bleifer
| Sociétés | Poste | Début |
|---|---|---|
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Corporate Officer/Principal | - |
Anciens postes connus de Craig B. Bleifer
| Sociétés | Poste | Fin |
|---|---|---|
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Conseiller Juridique Général | 01/01/2018 |
HealthCare Institute of New Jersey
 HealthCare Institute of New Jersey The HealthCare Institute of New Jersey is a trade association representing research-based biopharmaceutical, medical device, and diagnostic companies. The private company is based in Bridgewater, NJ. It advocates for policies that promote innovation, patient access to advanced medical products, and job creation within the life sciences sector. The organization collaborates with government, academia, and stakeholders to foster an innovation ecosystem and raise awareness of the industry’s clinical, economic, and social impact. It emphasizes corporate social responsibility, including commitments to philanthropy, environmental sustainability, ethical practices, and community engagement. The institute leads initiatives in diversity, equity, and inclusion, aiming to transform corporate culture, diversify supply chains, and address health inequities. It provides patient advocacy and assistance programs, such as the rx4nj partnership and njsave, which connect patients to prescription assistance and other support programs. Christine Buteas has been the CEO of the company since 2024. | Président | - |
Formation de Craig B. Bleifer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Vassar College
 Vassar College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
HealthCare Institute of New Jersey
HealthCare Institute of New Jersey The HealthCare Institute of New Jersey is a trade association representing research-based biopharmaceutical, medical device, and diagnostic companies. The private company is based in Bridgewater, NJ. It advocates for policies that promote innovation, patient access to advanced medical products, and job creation within the life sciences sector. The organization collaborates with government, academia, and stakeholders to foster an innovation ecosystem and raise awareness of the industry’s clinical, economic, and social impact. It emphasizes corporate social responsibility, including commitments to philanthropy, environmental sustainability, ethical practices, and community engagement. The institute leads initiatives in diversity, equity, and inclusion, aiming to transform corporate culture, diversify supply chains, and address health inequities. It provides patient advocacy and assistance programs, such as the rx4nj partnership and njsave, which connect patients to prescription assistance and other support programs. Christine Buteas has been the CEO of the company since 2024. | |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
New York University School of Law
 New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
